Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey.
BACKGROUND
The dosing regimen and indications for many medicines in current use in neonatology are not well defined. There is a need to prioritise research in this area, but currently there is little information about which drugs are used in UK neonatal units and the research needs in this area as perceived by UK neonatologists.


METHODS
The Neonatal Clinical Studies Group (CSG) of the Medicines for Children Research Network (MCRN) undertook a 2 week prospective scoping survey study to establish which medicines are used in UK neonatal units; how many babies are receiving them; and what clinicians (and other health professionals) believe are important issues for future research.


RESULTS
49 out of 116 units responded to at least one element of the survey (42%). 37 units reported the number of neonates who received medicines over a 2 week period. A total of 3924 medicine-patient pairs were reported with 119 different medicines. 70% of medicine-patient pairs involved medicines that were missing either a license or dose for either term or preterm neonates. 4.3% of medicine-patient pairs involved medicines that were missing both license and dose for any neonate. The most common therapeutic gap in need of additional research identified by UK neonatologists was chronic lung disease (21 responding units), followed by patent ductus arteriosus and vitamin supplements (11 responding units for both)


CONCLUSIONS
The research agenda for neonatal medicines can be informed by knowledge of current medicine use and the collective views of the neonatal community.
Turner
Mark A
MA
Division of Perinatal and Reproductive Medicine, University of Liverpool, Liverpool, UK. mark.turner@liverpool.ac.uk
Lewis
Sara
S
Hawcutt
Daniel B
DB
Field
D
D
D003625:Data Collection; D004363:Drug Utilization; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D009725:Nurseries, Hospital; D006113:United Kingdom
Br J Clin Pharmacol. 2007 Jun;63(6):689-97
17257162
BMJ. 2008 Nov 24;337:a2245
19029175
Clin Ther. 2006 Sep;28(9):1385-98
17062311
Drug Saf. 2002;25(1):1-5
11820908
J Clin Pharmacol. 2006 Sep;46(9):1038-43
16920899
Pediatrics. 2006 Jun;117(6):1979-87
16740839